BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11922858)

  • 1. The potential of dopamine agonists in drug addiction.
    Kosten TR; George TP; Kosten TA
    Expert Opin Investig Drugs; 2002 Apr; 11(4):491-9. PubMed ID: 11922858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor agonists, partial agonists and psychostimulant addiction.
    Pulvirenti L; Koob GF
    Trends Pharmacol Sci; 1994 Oct; 15(10):374-9. PubMed ID: 7809953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate in the treatment of substance-related disorders: a critical review of the literature.
    Shinn AK; Greenfield SF
    J Clin Psychiatry; 2010 May; 71(5):634-48. PubMed ID: 20361908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptor partial agonists and addiction.
    Moreira FA; Dalley JW
    Eur J Pharmacol; 2015 Apr; 752():112-5. PubMed ID: 25724788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of dual substance abuse and dependence.
    Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
    CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.
    Grabowski J; Shearer J; Merrill J; Negus SS
    Addict Behav; 2004 Sep; 29(7):1439-64. PubMed ID: 15345275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole, alcohol and substance abuse: a review.
    Brunetti M; Di Tizio L; Dezi S; Pozzi G; Grandinetti P; Martinotti G
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1346-54. PubMed ID: 23104650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine agonists for the treatment of cocaine dependence.
    Amato L; Minozzi S; Pani PP; Solimini R; Vecchi S; Zuccaro P; Davoli M
    Cochrane Database Syst Rev; 2011 Dec; (12):CD003352. PubMed ID: 22161376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.
    Brown ES; Jeffress J; Liggin JD; Garza M; Beard L
    J Clin Psychiatry; 2005 Jun; 66(6):756-60. PubMed ID: 15960570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine for cocaine dependence. A controlled clinical trial.
    Handelsman L; Rosenblum A; Palij M; Magura S; Foote J; Lovejoy M; Stimmel B
    Am J Addict; 1997; 6(1):54-64. PubMed ID: 9097872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bromocriptine: uses until now and prospects of new therapeutic applications].
    Górska D
    Neurol Neurochir Pol; 2000; 34(3):573-8. PubMed ID: 10979549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agents in development for the management of cocaine abuse.
    Gorelick DA; Gardner EL; Xi ZX
    Drugs; 2004; 64(14):1547-73. PubMed ID: 15233592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pharmacotherapeutic treatments for cocaine addiction.
    Shorter D; Kosten TR
    BMC Med; 2011 Nov; 9():119. PubMed ID: 22047090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The principles of agonist pharmacotherapy for psychostimulant dependence.
    Shearer J
    Drug Alcohol Rev; 2008 May; 27(3):301-8. PubMed ID: 18368612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.
    Van Skike CE; Maggio SE; Reynolds AR; Casey EM; Bardo MT; Dwoskin LP; Prendergast MA; Nixon K
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():269-87. PubMed ID: 26582145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for opioid and cocaine abuse.
    Warner EA; Kosten TR; O'Connor PG
    Med Clin North Am; 1997 Jul; 81(4):909-25. PubMed ID: 9222260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapies for adolescent substance use disorders.
    Simkin DR; Grenoble S
    Child Adolesc Psychiatr Clin N Am; 2010 Jul; 19(3):591-608. PubMed ID: 20682223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents.
    Newman AH; Grundt P; Nader MA
    J Med Chem; 2005 Jun; 48(11):3663-79. PubMed ID: 15916415
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.
    Heidbreder CA; Hagan JJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence.
    Malcolm R; Kajdasz DK; Herron J; Anton RF; Brady KT
    Drug Alcohol Depend; 2000 Aug; 60(2):161-8. PubMed ID: 10940543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.